Figure 2
Figure 2. IKK enzyme is active and the upstream signaling CBM complex is present in platelets. (A) Mouse and human platelets were held resting (R) or stimulated with thrombin (0.1 U/mL, 3 minutes; S) and extracts from them were subjected to immunoblotting with anti-CARMA1, anti-MALT1, anti-Bcl10, anti-IKK-α, anti-IKK-β, and anti-IKK-γ/NEMO antibodies. (B-C) Mouse platelets were preincubated with IKK inhibitors (BMS-345541, 5 μM; TPCA-1, 0.5 μM [B]) or BAY 11-7082, 12.5 μM; [C]) for 5 minutes and stimulated with thrombin prior to immunoblotting the extracts with anti-pSer32-IκB (pIκB) or anti-IκB antibodies.

IKK enzyme is active and the upstream signaling CBM complex is present in platelets. (A) Mouse and human platelets were held resting (R) or stimulated with thrombin (0.1 U/mL, 3 minutes; S) and extracts from them were subjected to immunoblotting with anti-CARMA1, anti-MALT1, anti-Bcl10, anti-IKK-α, anti-IKK-β, and anti-IKK-γ/NEMO antibodies. (B-C) Mouse platelets were preincubated with IKK inhibitors (BMS-345541, 5 μM; TPCA-1, 0.5 μM [B]) or BAY 11-7082, 12.5 μM; [C]) for 5 minutes and stimulated with thrombin prior to immunoblotting the extracts with anti-pSer32-IκB (pIκB) or anti-IκB antibodies.

Close Modal

or Create an Account

Close Modal
Close Modal